EPS Bio Technology Corp. (4183.TWO)
- Previous Close
20.00 - Open
20.00 - Bid 19.80 x --
- Ask 21.00 x --
- Day's Range
20.00 - 20.00 - 52 Week Range
18.70 - 30.60 - Volume
50 - Avg. Volume
16,752 - Market Cap (intraday)
476M - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
71.43 - EPS (TTM)
0.28 - Earnings Date --
- Forward Dividend & Yield 0.80 (4.00%)
- Ex-Dividend Date Jun 24, 2024
- 1y Target Est
--
EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.
www.epsbio.comRecent News: 4183.TWO
View MorePerformance Overview: 4183.TWO
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4183.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4183.TWO
View MoreValuation Measures
Market Cap
476.00M
Enterprise Value
455.36M
Trailing P/E
71.43
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.01
Price/Book (mrq)
1.56
Enterprise Value/Revenue
0.96
Enterprise Value/EBITDA
21.22
Financial Highlights
Profitability and Income Statement
Profit Margin
3.84%
Return on Assets (ttm)
0.62%
Return on Equity (ttm)
5.67%
Revenue (ttm)
451.08M
Net Income Avi to Common (ttm)
17.31M
Diluted EPS (ttm)
0.28
Balance Sheet and Cash Flow
Total Cash (mrq)
128.94M
Total Debt/Equity (mrq)
36.16%
Levered Free Cash Flow (ttm)
-60.98M